News|Articles|August 15, 2013

INFOGRAPHIC: Oral oncolytics

The pros and cons of oral oncolytics and intravenous drugs.

The pros and cons of oral oncolytics and intravenous drugs.


Related to this article

Medicare Part D redesign reshapes market
Part D enrollment has shifted: standalone plan offerings are down 22%, while special needs plans grew 21%, reshaping competition among fewer, larger sponsors nationally, finds an analysis by IPD Analytics.